On November 15, 2021 Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, reported that members of its senior management team will participate in two virtual investor conferences in November (Press release, Repare Therapeutics, NOV 15, 2021, View Source [SID1234595635]). Details are as follows :

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Northland Synthetic Lethality Investor Conference
Date: Wednesday, November 17, 2021
Time: 9:30 a.m. Eastern Time

Piper Sandler Healthcare Conference
Date: Monday, November 29 – Thursday, December 2, 2021

A live webcast of the Northland Synthetic Lethality Investor Conference panel discussions will be available starting Wednesday, November 17, 2021 at 9:30 a.m. Eastern Time in the Investor section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 90 days.

The prerecorded Piper Sandler Healthcare Conference fireside chat will be available on Monday, November 22, 2021 at 10 a.m. Eastern Time in the Investor section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 90 days.